This guideline provides recommendations to users and manufacturers of point-of-care coagulation testing devices for monitoring heparin and vitamin K antagonist therapy and for the evaluation of hemostasis, as well as to ensure reliable results comparable with those obtained by routine medical laboratory testing.
CLSI POCT14
$90.00
Point-of-Care Monitoring of Anticoagulation Therapy; Approved Guideline, POCT14AE
Category: CLSI
Related products
$134.00
$76.00
$114.00
$90.00
$79.00
$90.00